155
Participants
Start Date
June 19, 2015
Primary Completion Date
April 5, 2017
Study Completion Date
September 18, 2023
TAF
TAF 25 mg tablet administered orally once daily
TDF
TDF 300 mg tablet administered orally once daily
TAF Placebo
TAF placebo tablet administered orally once daily
TDF Placebo
TDF placebo tablet administered orally once daily
Beijing Ditan Hospital, Beijing
Peking University First Hospital, Beijing
No. 302 PLA Hospital, Beijing
Peking University People's Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Youan Hospital, Capital Medical University, Beijing
Shengjing Hospital of China Medical University, Shenyang
The sixth People's Hospital of Shenyang, Shenyang
The First Hospital of Jilin University, Changchun
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Public Health Clinical Center, Shanghai
85 Hospital of People's Liberation Army, Shanghai
Jiangsu Provincial People's Hospital, Nanjing
Jinan Infectious Disease Hospital, Jinan
The First Affiliated Hospital of Nanchang University, Nanchang
XiangYa Hospital Central South University, Changsha
The 2nd Xiangya Hospital Central South University, Changsha
Tongji Hospital, Tongji Medical college HuaZhong University of Science&Technology, Wuhan
Guangzhou No.8 People's Hospital, Guangzhou
Nanfang Medical University, Nanfang Hospital, Guangzhou
The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou
The 1st Affiliated Hospital of Guangxi Medical University, Nanning
The Affiliated Hospital of Guiyang Medical College, Guiyang
The People's Hospital of Hainan Province, Haikou
West China Hospital, Sichuan University, Chengdu
No.1 Hospital Affiliated to Kunming Medical College, Kunming
First Affiliated Hospital of Xi'an Jiaotong, Xi'an
The 3rd Hospital of Hebei Medical University, Shijiazhuang
Nanjing No. 2 Hospital, Nanjing
Lead Sponsor
Gilead Sciences
INDUSTRY